Heron Therapeutics, Inc. (HRTX)

Heron Therapeutics Statistics

Total Valuation

HRTX has a market cap or net worth of $321.91 million. The enterprise value is $448.49 million.

Market Cap	321.91M
Enterprise Value	448.49M

Important Dates

The last earnings date was Tuesday, May 6, 2025, before market open.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

HRTX has 152.56 million shares outstanding. The number of shares has increased by 4.72% in one year.

Current Share Class	152.56M
Shares Outstanding	152.56M
Shares Change (YoY)	+4.72%
Shares Change (QoQ)	+28.58%
Owned by Insiders (%)	0.87%
Owned by Institutions (%)	55.29%
Float	116.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	105.50
PS Ratio	2.17
Forward PS	1.97
PB Ratio	-11.31
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.02
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.40

Current Ratio	2.40
Quick Ratio	1.46
Debt / Equity	n/a
Debt / EBITDA	306.67
Debt / FCF	n/a
Interest Coverage	-0.59

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-0.99%
Return on Invested Capital (ROIC)	-1.52%
Return on Capital Employed (ROCE)	-2.43%
Revenue Per Employee	$1.22M
Profits Per Employee	-$63,811
Employee Count	122
Asset Turnover	0.65
Inventory Turnover	1.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.90% in the last 52 weeks. The beta is 1.33, so HRTX's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	-29.90%
50-Day Moving Average	2.22
200-Day Moving Average	1.91
Relative Strength Index (RSI)	47.04
Average Volume (20 Days)	1,820,537

Short Selling Information

The latest short interest is 32.96 million, so 21.61% of the outstanding shares have been sold short.

Short Interest	32.96M
Short Previous Month	32.52M
Short % of Shares Out	21.61%
Short % of Float	28.41%
Short Ratio (days to cover)	24.96

Income Statement

In the last 12 months, HRTX had revenue of $148.52 million and -$7.79 million in losses. Loss per share was -$0.06.

Revenue	148.52M
Gross Profit	95.50M
Operating Income	-3.58M
Pretax Income	-48.13M
Net Income	-7.79M
EBITDA	-1.22M
EBIT	-3.58M
Loss Per Share	-$0.06

Balance Sheet

The company has $50.68 million in cash and $177.26 million in debt, giving a net cash position of -$126.58 million or -$0.83 per share.

Cash & Cash Equivalents	50.68M
Total Debt	177.26M
Net Cash	-126.58M
Net Cash Per Share	-$0.83
Equity (Book Value)	-28.45M
Book Value Per Share	-0.19
Working Capital	124.28M

Cash Flow

In the last 12 months, operating cash flow was -$21.88 million and capital expenditures -$1.82 million, giving a free cash flow of -$23.70 million.

Operating Cash Flow	-21.88M
Capital Expenditures	-1.82M
Free Cash Flow	-23.70M
FCF Per Share	-$0.16

Margins

Gross margin is 64.30%, with operating and profit margins of -2.41% and -5.24%.

Gross Margin	64.30%
Operating Margin	-2.41%
Pretax Margin	-5.24%
Profit Margin	-5.24%
EBITDA Margin	-0.82%
EBIT Margin	-2.41%
FCF Margin	n/a

Dividends & Yields

HRTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.72%
Shareholder Yield	n/a
Earnings Yield	-2.42%
FCF Yield	-7.36%

Analyst Forecast

The average price target for HRTX is $5.50, which is 160.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.50
Price Target Difference	160.66%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	13.16%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 13, 2014. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jan 13, 2014
Split Type	Reverse
Split Ratio	0.05:1

Scores

HRTX has an Altman Z-Score of -9.4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.4
Piotroski F-Score	2